You Searched For "teva pharmaceuticals case" and got 20 results
Sort By:
2 mins read
Seven Indian pharma companies are being dragged into a US lawsuit over high drug prices
Seven Indian drugmakers - Sun Pharma, Dr Reddy’s Laboratories, Glenmark Pharma, Lupin Wockhardt…
3 mins read
4 healthcare firms just agreed to a deal to settle key opioids cases ahead of a trial
Already, Johnson & Johnson in August was ordered by a judge in Oklahoma to pay out $572 million…
Lydia Ramsey
3 mins read
Purdue Pharma is reportedly mulling an 8-figure settlement to resolve more than 2,000 opioid cases - and it would plunge the drugmaker into bankruptcy
A handful of opioid producers and distributors have already been affected by increased legal scruti…
Ben Winck
5 mins read
Because of the Adderall shortage, I had to call over 40 pharmacies to try and get my prescription filled — and I still didn't find it in stock anywhere
The Adderall shortages make it so hard to get prescriptions filled that I called over 40 pharmacies…
Sam Escobar
7 mins read
Trading intel with rivals and searching for 'dirt': Inside the secret communications that allegedly show how big drug companies plotted for years to increase the price of your medicines
The latest complaint has a similar focus on generic drugs and names a similar group of generic drug…
Emma Court
3 mins read
Trump has small financial interest in French pharma giant that makes hydroxychloroquine: NYT
"If hydroxychloroquine becomes an accepted treatment, several pharmaceutical companies stand to p…
PTI
10 mins read
A huge lawsuit accuses nearly 20 big drug companies, a billionaire and two brothers-in-law of cozying up to hike drug prices. Here's the inside story.
In a statement to Business Insider, Heritage said that it fired Malek and Glazer in 2016 after an i…
Emma Court
3 mins read
J&J was ordered to pay $572 million for helping fuel the opioid epidemic. The company's market cap increased $15 billion in response.
Opioid distributors McKesson, Cardinal Health, and AmerisourceBergen all fell as much as 7% in earl…
Ben Winck
3 mins read
Johnson & Johnson climbs after settling two opioid epidemic lawsuits, allowing it to avoid an upcoming federal trial
Featured Digital Health Articles: - Telehealth Industry: Benefits, Services & Examples - Valu…
Ben Winck
1 min read
Once again, a major corporation picked a boutique over a Wall Street mega-bank to advise on its multi-billion dollar deal
On one side of the deal, projected to be worth about $40 billion, is Teva Pharmaceuticals, which is…
Jonathan Marino
2 mins read
Things are finally really starting to hurt for the maker of EpiPen
Now to be fair, the entire generic drug industry has been getting whalloped this quarter. Same stor…
Linette Lopez
3 mins read
Allergan just struck another billion-dollar deal
But using acquisitions of promising drugs as a means to fatten a company's pipeline of products is …
Lydia Ramsey
2 mins read
The FDA just approved a 'complex generic drug' and it's sending one stock soaring and another crashing
"Mylan has invested tens of millions of dollars over many years to bring this important medicine to…
Lydia Ramsey
2 mins read
10 things you need to know before the opening bell
The head of the IMF says Trump is good for the US economy for now. Speaking at the annual World Gov…
Jonathan Garber
2 mins read
STOCKS GO NOWHERE: Here's what you need to know
1. The benchmark Puerto Rico bond fell to record lows after President Donald Trump said the US terr…
Elena Holodny
2 mins read
Valeant says it may sell its '$1 billion drug' and the stock is soaring
On February 1, 2013, Salix received a subpoena from the U.S. Attorney's Office for the Southern Dis…
Linette Lopez
3 mins read
10 things you need to know before European markets open
Latvia is mourning the loss of the drug used by Maria Sharapova. Latvia expressed sadness over the …
Ben Moshinsky
3 mins read
A woman who's worked in venture capital for 25 years shares her best career advice - and why it was worth being the first and only woman on her team when she started out
"Wende could be running a consumer products company if that's what she wanted to do," Steve James, …
Lydia Ramsey
3 mins read
Why Mylan could stand to make even more money off a generic version of the EpiPen
But say Mylan doesn't have to deal with some of those middlemen who make money along the way, and c…
Lydia Ramsey
5 mins read
Mylan's decision to make a cheaper, generic EpiPen 'baffles' experts
"I wonder whether their generic will be fully substitutable by pharmacists, a question which may de…